Dermapharm Holding SE (FRA:DMP)

Dermapharm Holding SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,173	1,195	1,150	1,040	959.6	807.64
Other Revenue	0.75	0.75	0.42	0.25	0.49	0.67
Revenue	1,174	1,195	1,151	1,041	960.09	808.31
Revenue Growth (YoY)	0.02%	3.89%	10.59%	8.38%	18.78%	13.15%
Cost of Revenue	419.03	445.6	446.6	391.85	349.87	354.42
Gross Profit	755.11	749.85	704.14	648.7	610.22	453.89
Selling, General & Admin	297.14	287.43	271.01	190.56	168.95	158.06
Other Operating Expenses	148.99	158.18	151.21	117.72	99.68	110.13
Operating Expenses	525.35	527.78	510.99	365.98	314.31	313.77
Operating Income	229.76	222.07	193.16	282.72	295.91	140.12
Interest Expense	-52.27	-58.41	-54.97	-12.34	-8.84	-9.36
Interest & Investment Income	8.09	13.99	2.49	0.33	4.02	0.51
Earnings From Equity Investments	1.13	1.52	-7.16	-13.54	0.32	-1.5
Currency Exchange Gain (Loss)	1.4	1.4	-1.95	0.37	2.28	-1.63
Other Non Operating Income (Expenses)	-8.6	-0.96	-16.63	-1.12	-0.83	0.24
EBT Excluding Unusual Items	179.51	179.61	114.93	256.43	292.86	128.38
Merger & Restructuring Charges	-	-	-	-	-0.6	-
Impairment of Goodwill	-2.12	-2.12	-	-36.45	-5.43	-
Gain (Loss) on Sale of Investments	-0	-0	-1.98	-	9.06	-
Gain (Loss) on Sale of Assets	0.63	0.63	2.96	3.13	1.38	0.23
Asset Writedown	-6.21	-6.21	-15.82	-7.03	-4.48	-3.58
Other Unusual Items	-	-	5.78	-	-	-
Pretax Income	171.9	172.01	106	216.3	292.98	125.28
Income Tax Expense	57.66	60.27	45.46	83.68	84.07	39.36
Earnings From Continuing Operations	114.25	111.74	60.53	132.62	208.9	85.93
Minority Interest in Earnings	1.78	2.05	1.83	1.62	0.68	-0.1
Net Income	116.03	113.79	62.37	134.24	209.58	85.83
Net Income to Common	116.03	113.79	62.37	134.24	209.58	85.83
Net Income Growth	28.09%	82.45%	-53.54%	-35.95%	144.19%	11.18%
Shares Outstanding (Basic)	54	54	54	54	54	54
Shares Outstanding (Diluted)	54	54	54	54	54	54
Shares Change (YoY)	-0.14%	-	-	-	-	-
EPS (Basic)	2.15	2.11	1.16	2.49	3.89	1.59
EPS (Diluted)	2.15	2.11	1.16	2.49	3.89	1.59
EPS Growth	28.27%	82.45%	-53.54%	-35.91%	144.65%	11.19%
Free Cash Flow	164.39	163.14	177.88	249.52	189.17	90.3
Free Cash Flow Per Share	3.05	3.03	3.30	4.63	3.51	1.68
Dividend Per Share	0.900	0.900	0.880	1.050	2.170	0.880
Dividend Growth	2.27%	2.27%	-16.19%	-51.61%	146.59%	10.00%
Gross Margin	64.31%	62.72%	61.19%	62.34%	63.56%	56.15%
Operating Margin	19.57%	18.58%	16.79%	27.17%	30.82%	17.34%
Profit Margin	9.88%	9.52%	5.42%	12.90%	21.83%	10.62%
Free Cash Flow Margin	14.00%	13.65%	15.46%	23.98%	19.70%	11.17%
EBITDA	257.07	250.77	220.31	302.36	312.36	155.05
EBITDA Margin	21.89%	20.98%	19.14%	29.06%	32.53%	19.18%
D&A For EBITDA	27.32	28.7	27.15	19.64	16.45	14.92
EBIT	229.76	222.07	193.16	282.72	295.91	140.12
EBIT Margin	19.57%	18.58%	16.79%	27.17%	30.82%	17.34%
Effective Tax Rate	33.54%	35.04%	42.89%	38.69%	28.70%	31.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.